Berberine inhibits enterovirus 71 replication by downregulating the MEK/ERK signaling pathway and autophagy

Huiqiang Wang1, Ke Li1, Linlin Ma1

  • 1Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.

Virology Journal
|January 14, 2017
PubMed
Abstract

Insights

Berberine (BBR) inhibits enterovirus 71 (EV71) replication by downregulating the MEK-ERK pathway and autophagy. This natural compound shows potential as an antiviral agent against EV71 infection.

Area of Science:

  • Virology
  • Molecular Biology
  • Pharmacology

Background:

  • Enterovirus 71 (EV71) replication is significantly influenced by the MEK-ERK signaling pathway and autophagy.
  • Inhibiting these pathways demonstrably impairs EV71 replication.
  • Berberine (BBR), a natural alkaloid, is known to modulate both signaling pathways and autophagy.

Purpose of the Study:

  • To investigate the potential of berberine (BBR) in inhibiting EV71 infection.
  • To determine if BBR exerts its antiviral effects by downregulating the MEK/ERK signaling pathway and autophagy.

Main Methods:

  • Antiviral effects were assessed using cytopathic effect (CPE) assays, western blotting, and qRT-PCR.
  • Mechanisms of action were elucidated via western blotting and immunofluorescence assays.

Main Results:

  • Berberine demonstrated a dose-dependent reduction in EV71 RNA and protein synthesis.
  • This inhibition was partly attributed to the downregulation of MEK/ERK signaling pathway activation.
  • Berberine suppressed EV71-induced autophagy by modulating AKT, JNK, and PI3KIII phosphorylation.

Conclusions:

  • Berberine effectively inhibits EV71 replication through the downregulation of autophagy and the MEK/ERK signaling pathway.
  • These findings highlight BBR as a potential therapeutic agent or supplement for managing EV71 infections.